Upgrade to SI Premium - Free Trial

aTyr Pharma (ATYR)

0.39 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form DEF 14A aTYR PHARMA INC For: Oct 16 September 11, 2026 4:06 PM - SEC Filing aTyr Pharma expects FDA response on Phase 3 sarcoidosis trial by mid-Sept September 1, 2026 4:39 PM - StreetInsider aTyr Pharma, Inc. (ATYR) Tops Q2 EPS by 1c August 10, 2026 6:00 AM - StreetInsider Form S-8 aTYR PHARMA INC August 7, 2026 4:11 PM - SEC Filing Form 10-Q aTYR PHARMA INC For: Jun 30 August 7, 2026 4:08 PM - SEC Filing Form 8-K aTYR PHARMA INC For: Aug 07 August 7, 2026 4:05 PM - SEC Filing aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD August 7, 2026 4:01 PM - Globe NewsWire Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: FMR LLC August 6, 2026 10:15 AM - SEC Filing Form 8-K aTYR PHARMA INC For: Jul 30 July 31, 2026 4:45 PM - SEC Filing Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: BlackRock, Inc. July 27, 2026 4:27 PM - SEC Filing aTyr Pharma to present efzofitimod subgroup data at WASOG 2026 July 15, 2026 8:00 AM - StreetInsider aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026 July 15, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: FEDERATED HERMES, INC. July 8, 2026 7:37 AM - SEC Filing Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing June 26, 2026 8:35 AM - StreetInsider Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - Globe NewsWire Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - StreetInsider Full Article List